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Abstract
Background: It is well-established that smoking and depression are associated in adolescents, but
the temporal ordering of the association is subject to debate.
Methods:  Longitudinal studies in English language which reported the onset of smoking on
depression in non clinical populations (age 13-19) published between January 1990 and July 2008
were selected from PubMed, OVID, and PsychInfo databases. Study characteristics were extracted.
Meta-analytic pooling procedures with random effects were used.
Results: Fifteen studies were retained for analysis. The pooled estimate for smoking predicting
depression in 6 studies was 1.73 (95% CI: 1.32, 2.40; p < 0.001). The pooled estimate for depression
predicting smoking in 12 studies was 1.41 (95% CI: 1.21, 1.63; p < 0.001). Studies that used clinical
measures of depression were more likely to report a bidirectional effect, with a stronger effect of
depression predicting smoking.
Conclusion: Evidence from longitudinal studies suggests that the association between smoking
and depression is bidirectional. To better estimate these effects, future research should consider
the potential utility of: (a) shorter intervals between surveys with longer follow-up time, (b) more
accurate measurement of depression, and (c) adequate control of confounding.
Background
Co-occurrence of tobacco use and depression has long
been a major concern because of the substantially
increased risk to health.[1] Most [2-12] but not all [13-
15], cross-sectional studies report a strong positive associ-
ation between smoking and depression. Furthermore,
how these health risks inter-relate temporally remains a
topic of debate. Specifically, there is no consensus on
whether smoking causes depression or depression causes
smoking in the natural course of tobacco use and depres-
sion.[16]
Several hypotheses have been put forward to explain the
possible mechanisms underlying the association between
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smoking and depression. The "self-medication" hypothe-
sis suggests that depression may lead to smoking because
people smoke to relieve symptoms of depression. [17-20]
In contrast, other authors have suggested that cigarette
smoking causes depression as nicotine exposure may
damage neurochemical pathways, such as monoamine
neurotransmission. [21-23] Bi-directional mechanisms in
which smoking and depression reinforce each other have
also been postulated.[12,23,24] Finally, Kendler (1993)
hypothesizes that there is no causal relationship and that
the perceived association is a function of underlying
shared environmental and genetic risk factors.[24]
Adolescence is regarded as the key period for the study of
the onset of smoking and depression co-occurrence. The
period of adolescence represents the peak of the incidence
of both smoking and depression.[25] More specifically
depressive symptoms tend to increase in early adolescence
and then become stable or decline in later adoles-
cence.[26] Similarly, most people who start smoking do
so before the age of 18. To study the co-occurrence of
smoking and depression it is necessary to investigate the
association prior to onset.
While cross-sectional studies find that depression and
smoking are associated among adolescents, longitudinal
studies are needed to address temporality. Since Kandel
and Davis [27] reported that depression in adolescents
could lead to the onset of smoking, several longitudinal
studies have assessed the relationship between smoking
and depression in adolescents.[12,16,28] In previous
reviews, Paperwalla et al. [12] and Schepis and Rao [28]
examined the etiology of depression and smoking in gen-
eral without conducting systematic search strategies or
analysis. Park and Romer [16] conducted a systematic,
descriptive analysis of cross-sectional and longitudinal
studies published up to 2005. However, their review was
limited by the lack of a quantitative component, and
inclusion of several papers using data from the same
cohort as independent studies.
This review focuses on longitudinal studies wherein tem-
porality can be ascertained, and it provides a quantitative
summary of estimates of the association between smoking
and depression among adolescents.
Methods
English language studies published between January 1990
and December 2007 were extracted from the PubMed,
OVID, and PsychInfo databases using the following
abstract keywords: (a) smoking, tobacco, cigarettes; (b)
depress* (c) child*, adolescen*, youth; (d) longitudinal,
cohort, follow-up. Titles and abstracts were then screened
to determine if publications met the following inclusion
criteria: (1) the association between smoking and depres-
sion was studied longitudinally; (2) the outcome (either
the onset of depression or the onset of smoking) was
measured when subjects were aged 13 -19 years; (3) the
study population was broadly representative of adoles-
cents (studies of clinic populations, the unemployed, the
incarcerated, and pregnant girls were excluded); and (4)
the effect of smoking on the onset of depression, or the
effect of depression on the onset of smoking was reported
explicitly as a risk, hazard, or odds ratio. Studies that
examined related but distinct mental health constructs
including anxiety, stress, and negative affect were not
included. Additional studies that met the inclusion crite-
ria were identified by scanning references in the reports
retained in the primary search, and through searching the
Internet through Google Scholar. For cohorts with multi-
ple relevant publications, the latest publication with the
longest follow-up that reported on outcomes in adoles-
cents was selected to avoid duplication.
The following data were abstracted from each study
retained: country in which the study had been conducted;
sample size; year(s) of data collection; time period over
which the relationship was estimated; participants' age/
grade, the definition of smoking; the definition of depres-
sion; covariates included in the multivariate modeling;
the analytic method; and the parameter estimate of the
unadjusted association between smoking and depression
(with 95% confidence intervals if available). Finally, the
estimate of effect(s) after controlling for covariates was
recorded. The quality of the studies included in this review
was characterized across factors that may affect generaliz-
ability and internal validity in cohort studies.[29] Several
studies reported only one direction of effect (i.e., smoking
initiation was the only outcome tested). Studies that
reported results only by subgroup (i.e., males and
females) were included as separate studies in the pooled
analysis.
Synthesis
While there was considerable variability in methods of
analysis and the description of results, we undertook a
quantitative synthesis of data across studies. The log scale
estimate and its standard error were entered into Stata
10.0 [30] and pooled using the 'meta' procedure with the
random effects option. This procedure uses inverse vari-
ance weighting to combine the effect measures. The
results for depression predicting the onset of smoking,
and smoking predicting the onset of depression were tab-
ulated separately, and forest plots were created for each
analytic group.
Sources of longitudinal studies
The database search yielded 191 publications. Eight addi-
tional reports were obtained through a search of refer-
ences. Sixteen publications were excluded because theyBMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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did not analyze the data longitudinally (i.e., they pooled
data across data collection waves and analyzed the data as
if they were cross-sectional). Screening of titles and
abstracts for inclusion and exclusion criteria produced a
total of 55 relevant publications representing 17 different
cohorts. Four studies from separate cohorts [31-34] did
not have data that could be extracted and were therefore
excluded. Thirteen studies met the inclusion criteria (Fig-
ure 1).
Study characteristics
Table 1 presents selected characteristics of the 13 studies
retained. Study participants were drawn primarily from
school-based samples except for the national longitudinal
study of adolescent health[35] and the Teenage Attitudes
and Practices Study (TAPs)[36] which were nationally rep-
resentative population samples in the United States, and
the Christchurch Health and development study which is
a birth cohort.[37] Studies were conducted in the follow-
ing geographic locations: the United States, Mid-Atlantic
states, Michigan, Oregon, Northern Virginia, Los Angeles
County, Albany, Pittsburgh, Australia, New Zealand, and
Hong Kong. A variety of analytic approaches were used
(i.e., logistic, ordinal logit, and Cox regression) which
yielded differing types of estimates of effect. All studies
were conducted as panel studies with interval censoring.
Six studies had only one follow-up survey. Two studies
collected follow-up data at 6-month intervals, six studies
collected data at annual intervals, and five studies col-
lected data at longer than one-year intervals. Five publica-
tions followed their cohorts in total for one year, while 5
followed for more than 3 years.
Internal validity and generalizability
Studies retained for analysis varied on a number of criteria
measuring "quality" that may have affected internal valid-
ity or generalizability (See additional file 1: qualityta-
ble.xls for more details). Most studies used populations
randomly selected from the population or a school sam-
pling frames--except Clark and Cornelius [38] who
recruited a convenience sample. Albers et al. [11] and
Gilpin et al. [39] had loss to follow up proportions greater
than 25%. All studies controlled at least for age and sex;
the range of other variables controlled for in multivariate
analysis varied considerably across studies (Table 2).
Table 3 describes indicators used to measure smoking in
the 13 studies retained for analysis. Smoking onset was
typically described as one puff on a cigarette. The defini-
tion of a "smoker" ranged from "had smoked a single cig-
arette" to "daily smoking". Some studies defined a smoker
using progression in stage of smoking including smoking
a first cigarette or an experimenter becoming a daily
smoker. Two studies included measures of smoking inten-
sity such as number of cigarettes per day.[26,37] Of the six
studies that examined onset of depression, three started
from a baseline population of never smokers, while the
others used baseline smoking to predict depression.
Because the number of studies available for comparison
was limited, we could not determine if or how the meas-
ure of smoking used affected the estimate of the associa-
tion with depression.
Major Depressive Disorder is defined in the Diagnostic and
Statistical Manual of Mental Disorders [40] as a period of at
least two weeks characterized by at least five severe and
persistent depressive symptoms. The symptoms must not
represent a normal reaction to the death of a loved one
and should not be due to an identifiable organic factor
such as a physical illness or drug exposure. While clinical
exams and structured interviews are the gold standards of
measurement[12], they tend to be too lengthy and com-
plex for use in large-scale longitudinal studies. Despite
measurement challenges, five studies used semi-struc-
tured interview based measures of depres-
sion.[26,38,41,42] The majority of studies however used
measures of depressive symptomatology (Table 3), the
most common of which were the Center for Epidemiol-
ogy Depression Scale (CES-D) and the Mellinger
Scale.[27,43-45] Three studies examined past history of
mental illness or depression.
Results
Descriptive Analysis
Six studies investigated smoking and depression as both
outcomes and predictors, allowing for direct assessment
of the bidirectionality of the association in the same study
population. Two of these six studies [41,46] reported that
smoking was a significant predictor of depression, but
depression did not predict smoking. All six bidirectional
studies found that smoking was predictive of depression;
however, two studies concluded that depression predict-
ing smoking was a better fit of the data.[26,37] While Fer-
gusson et al. did not present risk estimates for smoking
predicting depression, the authors concluded that the data
best fit the model that depression led to smoking.[37]
Brown (1996) and Lam (2004) in longitudinal surveys of
youth in Oregon and Hong Kong, respectively, all con-
cluded that depression predicted smoking or progression
of smoking, while increased smoking predicted increased
depression.[33,42,46-48]
Of the six studies that examined the bidirectionality of the
association between smoking and depression, the three
that used a clinical measure of depression [37,41,46]
found stronger effects for depression predicting smoking
than for smoking predicting depression. In the other three
studies that used a symptomatological measure of depres-
sion, the reverse was true.[35,46,48] Self-report measuresBMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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of depressive symptomology tend to overestimate preva-
lence compared to semi-structured clinical interviews.[28]
Several studies indicate that there may be effect modifica-
tion in the association and have identified different sub-
groups in which the relationships between smoking and
depression differ. Three studies found that the association
of smoking and depression was only significant among
females.[26,34,45] Patton (1998) found that depression
was predictive of smoking only in youth who reported
that all or most of their friends smoked.[26]
Pooled analysis
The pooled estimate for smoking predicting depression in
the six studies with available data was 1.73 (95% CI: 1.32,
2.40; p < 0.001) (Figure 2). The pooled estimate for the 12
studies that examined depression predicting smoking was
1.41 (95% CI: 1.21, 1.63; p > 0.001) (Figure 3). There was
no significant publication bias according to either Begg's
Test or Egger's Test for both depression and smoking out-
comes. Visual inspection of the bias plot (not shown) was
consistent with this statistical finding. There was statistical
heterogeneity in studies predicting depression and those
predicting smoking according to the Q test for heterogene-
ity (p = 0.08), and therefore a random effects model was
used for the meta-analysis of the data. Removal of the
largest study [36] predicting smoking did not dramatically
affect the estimate (1.37 (95% CI: 1.17, 1.60)).
Discussion
The present review suggests that there is evidence in longi-
tudinal studies of adolescents that depression predicts
smoking, and that smoking predicts depression. The
pooled estimates for depression predicting smoking (1.41
(95% CI: 1.21, 1.63)) and smoking predicting depression
(1.73 (95% CI: 1.32, 2.40)) were both statistically signifi-
cant despite the relatively small number of studies and
wide variability in study designs and measures.
This analysis revealed moderately strong evidence sup-
porting a relationship whereby smoking predicts depres-
sion among adolescents. Only one study [11] found that
smoking did not significantly predict depression, but this
study had the smallest sample size of the studies included,
and the magnitude of the effect was large (1.74). The mag-
nitude of the pooled effect for smoking predicting depres-
sion was also larger than that of depression predicting
smoking. There is evidence that smoking leads to dysreg-
ulation of the hypothalamic-pituitary-adrenal system and
hypersecretion of cortisol [49], which can regulate biolog-
ical and psychological reactions to sources of stress. [50-
52] Consequently, smoking might interfere with natural
adaptive coping mechanisms and induce depression.[53]
Conversely, the results also may be interpreted to suggest
that depression leading to smoking is the more likely
pathway. Smokers may use nicotine as a means of 'self-
medicating' symptoms such as depressed mood and
fatigue that are related to depression; nicotine has been
shown to produce an elevation in mood.[24] Nicotine
may also have anti-depressant properties, acting in a sim-
ilar manner to common antidepressants through the sero-
tonin neurotransmitters. [54-56] In the few studies that
tested competing models directly, depression predicting
Search strategy diagram Figure 1
Search strategy diagram.BMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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smoking was the stronger effect. When more specific
measures of depression are used, depression is better able
to predict smoking, suggesting that random misclassifica-
tion of depression may bias the effect of depression pre-
dicting smoking towards the null in some studies.
Furthermore, smoking may be more easily quantified and
recalled by adolescents--more studies measure previous
smoking history (i.e., identify never smokers) and control
for it than measure previous depression or control for pre-
vious depressive episodes. If depression at a young age
went undiagnosed at the time, it is possible and perhaps
likely that previous depression would have been forgotten
or mischaracterized. While it is possible to forget smoking
experiences, smoking is a tangible event compared to a
depressive episode. Controlling for previous smoking
without controlling for previous depression will create
bias by design.
The current analysis cannot refute the hypothesis that the
relationship between smoking and depression is spurious.
It is possible that if the two conditions are causally related,
the relationship may reflect several potential causal mech-
anisms in which: (a) depression precedes smoking, (b)
smoking precedes depression, (c) there is a bidirectional
relationship between smoking and depression, (d) the
relationship is a function of unknown risk factors, or (e)
there are subgroups in which the relationship between
smoking and depression differs. To address these issues,
the nature of the relationship between depression and
smoking should be investigated further. While temporal-
ity is an important condition for causality, there are other
issues in the current literature of prospective studies that
limit our ability to draw robust conclusions about the
nature, causal or otherwise, of the relationship between
smoking and depression. These issues should inform
future research and are discussed below.
Table 1: Characteristics of longitudinal studies on the relationship between depression and smoking among adolescents.
First 
Author
Year Where 
study took 
place
Baseline 
age or 
grade
Follow-up 
period
n Method of 
analysis
Estimate of effect 
of smoking 
predicting 
depression
Estimate of effect of 
depression predicting 
smoking
Brown 1996 Western 
Oregon
14 to 18 
years
1 year 1507 Logistic 
regression
OR = 1.89 
(1.04, 3.45)
OR = 2.04 (1.16,3.60)
Escobedo 1998 United States 12 to 18 
years
1 year 7885 Logistic Not assessed OR = 1.30 (1.10, 1.60)
Patton 1998 Victoria, 
Australia
Grades 9 to 
12
every 6 
months for 3 
years
1688 person years/
time varying 
Survival analysis
Not assessed HR = 2.00 (1.30, 2.90) 
Significant among girls 
only
Wu 1999 Mid Atlantic 
US
8 and 9 
years
Every 6 
months, 1 
year
1731 Survival analysis HR = 1.66 1.28, 2.16 HR = 1.06 (0.74, 1.51)
Goodman 2000 United States Grade 7 to 
12
2 years 8704 Logistic OR = 3.90 
(1.85, 8.20)
OR = 1.72 (0.78, 3.81)
Albers 2002 Massachusset
s
12-15 years 
old
4 years 522 Logistic OR = 1.74 
(0.97, 3.14)
Not assessed
Fergusson 2003 New Zealand Birth every year, 
21 years
1265 Incidence ratio Not assessed RR 1.75 (1.13, 2.70)
Lam 2004 Hong Kong Grade 7 1 year 1894 Logistic OR = 2.17 (1.40,3.36) OR 1.48 (1.07, 2.05)
Audrain-
McGovern
2004 Northern 
Virginia
Grade 9 Every year, 3 
years
615 Ordinal logit Not assessed OR = 1.04 (0.76, 1.42)
Clark 2004 Pittsburgh 10 to 12 
years
2 years, 3 
years, 3 
years
572 Survival analysis Not assessed HR = 1.0
Killen 1997 Northern 
California
Grade 9 1 year for 4 
years
1901 Survival analysis Not assessed Girls: HR = 1.55 (n = 463 
x2 = 4.91), boys: HR = 
1.03 (n = 481, x2 = 7.84)
Gilpin 2004 California 12 to 15 
years old
1 year 1764 Logistic Not assessed OR = 1.46 (1.04, 2.05)
Brook 1998 Albany and 
Saratoga
1 to 10 
years
3 years, 6 
years, 5 
years
975 Logistic OR = 1.19 
(1.01, 1.40)
OR = 1.12 (0.28, 4.44)
OR = odds ratio
HR = hazard ratio
RR = risk ratioBMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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Table 2: Covariates included in final multivariate models reported in 13 longitudinal studies that examined the association between 
smoking and depression in adolescents.
Covariate Study(ies) that included the covariate in the final multivariate model (citation number)
Age (all)
Sex (all)
alcohol use [26,32,33,37,45,46,65]
parental education [32,36,41,42,61,66]
family income [32,37,41,61,66]
race/ethnic group [32,35-37,42,46,65]
smoking among peers [26,32,33,37,45,65,66]
parental smoking [26,32,36,66]
marijuana/other drug use [32,33,41,65]
Academic performance [32,36,37,65]
physical activity [26,65]
temperament [33]
social support [33]
parental attachment [37]
Anxiety [31,37]
Childhood adversity [37]
conduct problems [37,66]
novelty-seeking [37]
neuroticism [37]
drive for thinness [45]
Table 3: Measures of smoking and depression used in 13 longitudinal studies that examined the association between smoking and 
depression in adolescents
Measures of smoking Study(ies) that used the measure
One puff [11,39,45,65]
One cigarette [26,27,34,38,46,48,76]
Ever (over 100 cigarettes) [36]
No cigarettes in past 6 months [33]
Last 30 days [35,48,72]
Daily smoking [26]
Total months of use [27]
No. cigarettes per day [37]
Three or more cigarettes per week [42]
DSM nicotine dependence [37]
Measures of depression Study(ies) that used the measure
Structured or semi structured
Kiddie-Schedule for Affective Disorders [42]
DIS for Children [41]
DSM-III-R [38]
Child and Adolescent Psychiatric Assessment [31,66]
High Clinical Interview Schedule [26]
Symptomatological
CES-D [33,35,45,65]
Depressed mood questions (unknown scales) [32,39,46]
Mellinger Scale [34,36,71]BMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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Misclassification
The conceptualization, the definition and the method of
measurement of exposure can affect the interpretation of
an association. Studies that used a clinically based defini-
tion of depression were generally consistent in showing
that the magnitude of effect was greater for depression
predicting smoking than smoking predicting depression;
however, only 5 studies used diagnostic interviews to
measure depression. Measures of depressive symptoma-
tology may have more random measurement error than
diagnostic interviews, attenuating parameter estimates
towards the null. Furthermore, cut-points for depressive
symptomatology scales unnecessarily discard informa-
tion.
Interval censoring may affect the interpretation of the
temporal sequence of events if both depression and smok-
ing occur during the same interval. For example, smokers
may experience rapid fluctuations in mood (compared to
non-smokers), as result of intermittent periods of with-
drawal, followed by short-term relief after smoking.[57]
These rapid fluctuations may cause misclassification of
the magnitude of depression symptoms depending on the
precise timing of administration of the survey. Shortening
the length of the interval will ameliorate this issue.
Selection bias
Sample selection may introduce bias. A previous history
of depression increases the risk of future depression,
which suggests that estimates should be adjusted for a his-
tory of depression.[25] Selecting adolescents without
smoking or depression at study entry reduces the need to
control for the possible effects of a history of either
depression or smoking. However, selecting such a sub-
group may also introduce bias by studying a unique sub-
group whose initiation of smoking or depressive
symptoms is potentially unusually delayed compared to a
'normal' population. This subgroup perhaps represents a
distinct population where the relationship between smok-
Effect sizes and 95% confidence intervals reported in six longitudinal studies on smoking predicting depression in adolescents Figure 2
Effect sizes and 95% confidence intervals reported in six longitudinal studies on smoking predicting depression 
in adolescents.BMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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ing and depression differs from a representative popula-
tion.
Unmeasured confounding
The magnitude of the association between depression and
smoking has been shown to be substantially reduced after
controlling for such variables as school performance,
socio-economic status, and alcohol use.[42,58-60] Dun-
can et al. argued that these variables (conceptualized in
these analyses as confounders) might in fact be indicators
of depression; and therefore it is inappropriate to include
them in the model.[61] Nevertheless, this current review
shows that these variables are unlikely to be mediators as
they do not consistently or entirely attenuate the relation-
ship; however, many studies did not control for the entire
range of covariates suggested as possible confounders. It is
also conceivable that other unknown or unmeasured
common factors are responsible for a spurious relation-
ship between depression and smoking. The identification
of whether potential covariates are confounders of the
depression and smoking relationship or mediators is a key
question for future research. Techniques such as pathway
analysis or structured equation modeling could be used to
test for mediation.[62] Direct acyclic graphing may also
be useful to help select appropriate confounders.[63,64]
Subgroups with different causal pathways
The evidence is consistent with a hypothesis that the asso-
ciation between smoking and depression may differ
among different subgroups. There is some indication that
the relationship between depression and smoking is spe-
cific to females or among youth with friends who
smoke.[26,34,45] There may also be undefined sub-
groups in which smoking leads to depression while in
others, depression leads to smoking--an hypothesis that is
consistent with the results of the present study. Audrain
McGovern et al. report that there was a significant rela-
tionship of smoking and depression only among adoles-
cents with variants of DRD2, a dopamine receptor
gene.[65] In a twin study, Silberg found that genetic influ-
ences were only pronounced among females for progres-
sion to smoking, and that for males, environmental
influences, particularly family and peer smoking,
explained the variance between smoking and depres-
Effect sizes and 95% confidence intervals reported in 12 longitudinal studies on depression predicting smoking in adolescents Figure 3
Effect sizes and 95% confidence intervals reported in 12 longitudinal studies on depression predicting smoking 
in adolescents.BMC Public Health 2009, 9:356 http://www.biomedcentral.com/1471-2458/9/356
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sion.[66] As well, the association of depression and smok-
ing may vary based on contextual factors such as
prevalence of depression or smoking in the population
and social acceptability of smoking.[67,68] The inconsist-
ency across studies examining smoking and depression
may relate to differences in environmental and subgroup
variations.
Limitations
This paper used strict inclusion criteria to include as
homogenous a population of studies as possible in order
to perform the pooled analysis. As such, studies that used
techniques such as growth curve modeling [33,69,70],
cross-lagged analysis [71], or correlations[34,72] were not
included. While broader would have included more stud-
ies and different perspectives, the advantage of a focused
research question allows the important information to be
highlighted and quantified in a way that a broader survey
could not.
The pooled estimates should be interpreted with caution
because they are based on studies with heterogeneous
measures of exposure and outcomes, and differing study
designs. Estimates adjusted for covariates were selected
from each study, but the variables included to control for
confounding varied from study to study. There may there-
fore be residual confounding of the pooled estimate,
which could inflate the estimate away from the 'true'
value.[73]
Several studies were excluded because the outcome was
measured in young adulthood rather than adoles-
cence.[47,74] It could be argued that the young adult
measure is more acceptable as it reduces the number of
censored observations. However, one major purpose of
studying adolescents is to capture the initiation of the
relationship between smoking and depression. The
strength of the association between smoking and depres-
sion is well established before age 20 and consequently
the initiation of the relationship must be established by
this point. Dramatic developmental and neurobiological
changes in the adolescent brain may influence drug use
vulnerability and future susceptibility to depression and,
consequently, the likelihood that an association exists
may differ across ages.[75]
Conclusion
While the association between smoking and depression is
not in doubt, the reasons underlying the association mat-
ter both for those affected by both depression and smok-
ing, but also for the development and implementation of
interventions. Understanding the causal mechanisms
underlying the relationship could allow for the develop-
ment of interventions for adolescents with these condi-
tions, and possibly prevent the implementation of
interventions based on an erroneous causal mechanism
that may have negligible or even iatrogenic effects. If, for
example, some individuals smoke in order to control
symptoms of depression, interventions that focus solely
on smoking could be ineffective, or indeed, potentially
dangerous. However, if smoking exacerbates depression
symptoms, excluding those who are depressed from treat-
ment could lead to further harm. Further research into
identifying the nature of the association should be initi-
ated.
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